Bio Protocol (BIO): D-Score 23/100 — Centralized Leaning BlockIndex D-Score: 23/100 (Centralized Leaning). Bio Protocol (BIO) is a Layer 2 cryptocurrency using Other consensus. Bio Protocol (BIO): ERC-20 AI-driven biotech platform powering domain-specific BioAgents, staking, and BioDAO deployments. Source: https://blockindex.ai/coin/bio · Data by BlockIndex.AI · Updated 2026-06-19 D-Score breakdown (0-100, higher means more decentralized) Component: Score: Overall D-Score: 23: Node distribution: 0: Initial distribution: 0: Governance: 16: Age and history: 7: Autonomy: 0: Key facts - Layer: Layer 2 - Consensus: Other (N/A) - Launch: Other - Founder: Vincent Weisser, Paul Kohlhaas - VC funded: No - Max supply: 3,320,000,000 - Circulating: 2,212,792,924 (66.7%) Market data (as of 2026-06-19) - Price: $0.03 - Market cap: $77.38M - 24h volume: $76.52M - 24h change: +2.18% · 7d change: +10.19% About Bio Protocol (BIO) is an AI-driven biotech platform and ERC-20 token designed to decentralize scientific automation and incentivize the deployment and operation of specialized AI agents called BioAgents. The protocol’s stated mission is to enable researchers, BioDAOs, and participant operators to access domain-focused AI models and workflows for tasks across longevity, men’s health, and microbiome research. BIO functions as the utility token within this ecosystem: holders can stake BIO to run BioAgents locally or in the cloud, participate in the Bio V2 Launchpad to deploy new agents, and engage in economic activities that align incentives between researchers, infrastructure providers, and consumers of biotech compute. The project positions itself at the intersection of decentralized governance, specialized AI tooling, and tokenized incentives to accelerate experimental throughput in biotech domains. Technically, Bio Protocol is a tokenized application layer on Ethereum, implemented as an ERC-20 contract (contract address provided in the source material). The protocol emphasizes a hybrid execution model for BioAgents that balances privacy-sensitive local compute with cloud-based scalable compute resources, enabling participants to choose execution environments depending on data sensitivity and processing requirements. The sources describe product primitives such as the Bio V2 Launchpad — a mechanism to create and distribute BioAgents — and staking mechanics that tie token economics to agent operation. The token model, supply figures, and contract address are visible in market-data snapshots (CoinMarketCap and CoinGecko references), but low-level on-chain governance mechanisms, smart contract internals, and developer tooling references are not detailed in the supplied materials. From a tokenomics and market perspective, the supplied data include clear supply and price snapshots: a max supply of 3.32B BIO, circulating supply reported at roughly 1.89B BIO, tens of thousands of holders (43.28K reported), and market metrics (price, market cap, 24h volume) visible in CoinMarketCap data excerpts. The sources record an ATH of $0.9226 (Jan 3, 2025) and a noted ATL entry (Oct 10, 2025). While those market milestones are documented, the scraped materials omit an explicit launch date, token decimals, chain ID, premine allocations, founder biographies, legal entity formation, and a formal governance schedule. Those omissions limit deep tokenomic and trust analysis based solely on the provided extracts. Governance and organizational details are sparse in the supplied files. The materials reference BioDAOs and the idea of communities deploying BioAgents, but they do not document an on-chain DAO, a concrete voting mechanism, or an executive team with named leadership. Because the scraped content lacks a whitepaper link, GitHub repository, or explicit legal/foundation disclosure, governance-related fields remain unspecified. The infrastructure and services sections reference common market-data and explorer tooling (CoinMarketCap, CoinGecko, DEX Mode, Chainz/Cryptoid) and mention Chainlink generically; however, direct integrations, oracle feeds, treasury governance, and regulator interactions are not described. Overall, the supplied materials present a marketed product pitch and market snapshot for an ERC-20 utility token focused on decentralized biotech AI, but leave key DSCORE-critical governance, distribution, and provenance details unresolved and in need of primary-source verification. Links - Website: https://app.bio.xyz/markets - Whitepaper: https://bio.xyz/documents/bio-whitepaper.pdf - GitHub: N/A --- About the D-Score: BlockIndex.AI rates decentralization from 0 to 100 across node distribution, initial distribution, governance, age and history, and autonomy. Methodology: https://blockindex.ai/dscore